UCI – Das Tumorzentrum Bern - Navigation
{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Naveen, K., Bilinska, A., Men\u00e9ndez, E., L\u00e4ppchen, T., Moon, E. S., Zoltowska, M., Pawlak, D., Cieszykowska, I., Mikolajczak, R., R\u00f6sch, F., Rominger, A., \u0026 Gourni, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/223311\u0022\u003EA true theranostic pair - 44\/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Nuclear Medicine and Molecular Imaging\u003C\/i\u003E.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Bilinska, A., Naveen, K., Gnesin, S., L\u00e4ppchen, T., Men\u00e9ndez, E., Martin, M., R\u00f6sch, F., Rominger, A., \u0026 Gourni, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/220911\u0022\u003EPreclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Nuclear Medicine and Molecular Imaging\u003C\/i\u003E.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Bilinska, A., Ballal, S., Bal, C., L\u00e4ppchen, T., Pilatis, E., Men\u00e9ndez, E., Moon, E. S., Martin, M., R\u00f6sch, F., Rominger, A., \u0026 Gourni, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/206132\u0022\u003EImproved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Nuclear Medicine and Molecular Imaging\u003C\/i\u003E, \u003Ci\u003E52\u003C\/i\u003E, 3238-3251.","year":2025,"type":"Journal Article (Original Article)"},{"title":"L\u00e4ppchen, T., Bilinska, A., Pilatis, E., Men\u00e9ndez, E., Imlimthan, S., Moon, E. S., Afshar Oromieh, A., R\u00f6sch, F., Rominger, A. O., \u0026 Gourni, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179136\u0022\u003ETailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2\u003C\/a\u003E. \u003Ci\u003EMolecules\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(13).","year":2024,"type":"Journal Article (Original Article)"},{"title":"D\u2019Onofrio, A., Engelbrecht, S., L\u00e4ppchen, T., Rominger, A. O., \u0026 Gourni, E. (2023). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171857\u0022\u003EGRPR-targeting radiotheranostics for breast cancer management.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EFrontiers in Medicine\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E, 1250799.","year":2023,"type":"Journal Article (Review)"},{"title":"Escudero Castellanos, A., Imlimthan, S., Men\u00e9ndez, E., Moon, E. S., L\u00e4ppchen, T., Rathke, H. G., Afshar Oromieh, A., Roesch, F., Rominger, A. O., \u0026 Gourni, E. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116223\u0022\u003ETumor stroma diagnostic imaging by a 68Ga-coupled small-molecule fibroblast activation protein (FAP) inhibitor: first pre-clinical data\u003C\/a\u003E. In \u003Ci\u003ENuclear medicine and biology\u003C\/i\u003E (Vol. 108-109, pp. S186-S187). Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2022. Elsevier.","year":2022,"type":"Conference Paper (Abstract)"},{"title":"Birindelli, G., Drobnjakovic, M., Morath, V., Alessandria, C., Gourni, E., Afshar Oromieh, A., Weber, W., Rominger, A. O., Eiber, M., \u0026 Shi, K. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116225\u0022\u003EIn silico study on the heterogeneity of the dose distribution and radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy\u003C\/a\u003E. In \u003Ci\u003ENuklearmedizin\u003C\/i\u003E (Vols. 61, Issues 02, pp. 175-176). 60. Jahrestagung der Deutschen Gesellschaft f\u00fcr Nuklearmedizin, Leipzig. Thieme.","year":2022,"type":"Conference Paper (Abstract)"},{"title":"Imlimthan, S., Men\u00e9ndez, E., Escudero-Castellanos, A., Moon, E., L\u00e4ppchen, T., Rathke, H. G., Afshar Oromieh, A., R\u00f6esch, F., Rominger, A. O., \u0026 Gourni, E. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116224\u0022\u003EPreclinical evaluation of a 68Ga-labeled squaric acid-based FAP inhibitor for PET applications\u003C\/a\u003E. In \u003Ci\u003ENuklearmedizin\u003C\/i\u003E (Vols. 61, Issues 02, pp. 165-166). 60. Jahrestagung der Deutschen Gesellschaft f\u00fcr Nuklearmedizin, Leipzig. Thieme.","year":2022,"type":"Conference Paper (Abstract)"},{"title":"Imlimthan, S., Men\u00e9ndez, E., Escudero Castellanos, A., Moon, E. S., L\u00e4ppchen, T., Rathke, H. G., Afshar Oromieh, A., Roesch, F., Rominger, A. O., \u0026 Gourni, E. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116222\u0022\u003EInvestigation of 68Ga\/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications\u003C\/a\u003E. In \u003Ci\u003ENuclear medicine and biology\u003C\/i\u003E (Vol. 108-109, pp. S56-S57). Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2022. Elsevier.","year":2022,"type":"Conference Paper (Abstract)"},{"title":"Birindelli, G., Drobnjakovic, M., Morath, V., Steiger, K., D\u2019Alessandria, C., Gourni, E., Afshar Oromieh, A., Weber, W., Rominger, A. O., Eiber, M., \u0026 Shi, K. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/58487\u0022\u003EIn silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapy\u003C\/a\u003E. \u003Ci\u003EAnnual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)\u003C\/i\u003E, \u003Ci\u003E2021\u003C\/i\u003E, 4497-4500.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Imlimthan, S., Moon, E. S., Rathke, H. G., Afshar Oromieh, A., R\u00f6sch, F., Rominger, A. O., \u0026 Gourni, E. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59663\u0022\u003ENew Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EPharmaceuticals\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(10).","year":2021,"type":"Journal Article (Review)"},{"title":"Alberts, I. L., H\u00fcnermund, J.-N., Sachpekidis, C., Zacho, H. D., Mingels, C., Dijkstra, L., Bohn, K. P., L\u00e4ppchen, T., Gourni, E., Rominger, A. O., \u0026 Afshar Oromieh, A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57618\u0022\u003ECombination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET\/CT: Effects on Lesion Visibility and Radiotracer Uptake\u003C\/a\u003E. \u003Ci\u003EJournal of Nuclear Medicine\u003C\/i\u003E, \u003Ci\u003E62\u003C\/i\u003E(9), 1252-1257.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Birindelli, G., Drobnjakovic, M., Morath, V., Steiger, K., D\u2019Alessandria, C., Gourni, E., Afshar Oromieh, A., Weber, W., Rominger, A. O., Eiber, M., \u0026 Shi, K. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57930\u0022\u003EIs Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(14).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Hofstetter, M. T., Moon, E. S., D\u2019Angelo, F., Geissb\u00fchler, L., Alberts, I. L., Afshar Oromieh, A., R\u00f6sch, F., Rominger, A. O., \u0026 Gourni, E. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55771\u0022\u003EEffect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist\u003C\/a\u003E. \u003Ci\u003EEJNMMI Radiopharmacy and Chemistry\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(1), 29.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Alberts, I. L., Sachpekidis, C., Dijkstra, L., Prenosil, G., Gourni, E., Boxler, S., Gross, T., Thalmann, G., Rahbar, K., Rominger, A. O., \u0026 Afshar Oromieh, A. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/185559\u0022\u003EThe role of additional late PSMA-ligand PET\/CT in the differentiation between lymph node metastases and ganglia\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Nuclear Medicine and Molecular Imaging\u003C\/i\u003E, \u003Ci\u003E47\u003C\/i\u003E(3), 642-651.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Alberts, I. L., Sachpekidis, C., Gourni, E., Boxler, S., Gross, T., Thalmann, G., Rahbar, K., Rominger, A. O., \u0026 Afshar Oromieh, A. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182921\u0022\u003EDynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Nuclear Medicine and Molecular Imaging\u003C\/i\u003E, \u003Ci\u003E47\u003C\/i\u003E(1), 160-167.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Mix, M., Reichel, K., Stoykow, C., Bartholom\u00e4, M., Drendel, V., Gourni, E., Wetterauer, U., Schultze-Seemann, W., Meyer, P. T., \u0026 Jilg, C. A. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/63617\u0022\u003EPerformance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Nuclear Medicine and Molecular Imaging\u003C\/i\u003E, \u003Ci\u003E45\u003C\/i\u003E(12), 2062-2070.","year":2018,"type":"Journal Article (Original Article)"}]}
